Recruiting
Phase 1

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Sponsor:

National Cancer Institute (NCI)

Code:

NCT05803382

Conditions

Metastatic Colorectal Carcinoma

Metastatic Malignant Solid Neoplasm

Stage IV Colorectal Cancer AJCC v8

Unresectable Colorectal Carcinoma

Unresectable Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BET Bromodomain Inhibitor ZEN-3694

Biopsy

Biospecimen Collection

Capecitabine

Computed Tomography

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information